Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors

Manish Dixit1, Brajendra K Tripathi, Akhilesh K Tamrakar

  • 1Division of Medicinal and Process Chemistry, Central Drug Research Institute, Lucknow 226001, India. agoel13@yahoo.com

Insights

Researchers identified novel inhibitors for Protein Tyrosine Phosphatase 1B (PTP-1B), an enzyme linked to insulin resistance and obesity. These compounds show promising activity in blocking PTP-1B, offering potential therapeutic avenues.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Metabolic Diseases

Background:

  • Protein tyrosine phosphatase 1B (PTP-1B) is a key negative regulator of insulin signaling.
  • PTP-1B dephosphorylates the insulin receptor, diminishing insulin sensitivity.
  • PTP-1B dysregulation is implicated in insulin resistance and obesity.

Purpose of the Study:

  • To identify and evaluate novel inhibitors of PTP-1B.
  • To explore the potential of hydroxy benzofuran derivatives as therapeutic agents for metabolic disorders.

Main Methods:

  • Synthesis and screening of hydroxy benzofuran methyl ketones, dimers, furanochalcones, and flavones.
  • In vitro evaluation of inhibitory activity against PTP-1B.

Main Results:

  • Several screened compounds exhibited significant PTP-1B inhibitory activity.
  • The evaluated chemical series demonstrated potential as PTP-1B inhibitors.

Conclusions:

  • Hydroxy benzofuran derivatives represent a promising class of PTP-1B inhibitors.
  • These findings could lead to new treatments for obesity and insulin resistance.